BioBricks, Biopunks and Bioentrepreneurs
Chapter 8: How will patents affect synthetic biology?
Chapter 8 investigates the interaction between patent law and synthetic biology, in the context of longstanding debate over patenting and the life sciences. It evaluates the likelihood of patents having an unintended negative impact on synthetic biology innovation. It also explores the application of case law on patentable subject matter, including the Myriad cases. This case law is unlikely to preclude patenting of various tools and processes within synthetic biology. Chapter 8 further argues that promoting synthetic biology innovation requires regulation to be directed to encouraging sharing and open access within synthetic biology research, and promoting patent quality. The chapter explores the patent examining practices of the United States Patent and Trademark Office in relation to several families of patent applications filed by scientists of the J Craig Venter Institute. The case study shows that patent law principles and examining practices have worked well in relation to these applications.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.